Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Analyst Comment

NeoDynamics - Long term financing

By Claus ThestrupCEO, Sweden
NeoDynamics

NeoDynamics - Long term financing, intends to carry out a Rights Issue of units for an initial amount of up to approximately SEK 72 million to finance commercialization and marketing activities in the USA and Europe. 

Prospectus will be published around the 31st. of July. The EGM takes place the 27th. of July - 2023.

Until the issue is carried out, Gryningskust, Rentability Sweden AB and Formue Nord Markedsneutral A/S will provide NeoDynamics with a loan of SEK 15,5 mio.

The rights issue is backed by largest shareholders, board of directors and management by 80%.

The EGM takes place the 27th. of July - 2023.

Read full announcement here:  Rights issue

Disclaimer:

HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. /ANALYST Claus Thestrup 8:00 AM 06-26-2023.

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.